vs
ICU MEDICAL INC（ICUI）与VinFast Auto Ltd.（VFS）财务数据对比。点击上方公司名可切换其他公司
VinFast Auto Ltd.的季度营收约是ICU MEDICAL INC的1.3倍（$718.6M vs $540.7M），VinFast Auto Ltd.净利率更高（-2.8% vs -2.9%，领先0.1%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
VinFast Auto Ltd.是越南跨国汽车企业，由越南最大私营综合企业集团之一Vingroup创立。Vingroup由越南知名企业家潘日旺创办，业务覆盖地产、零售、医疗、科技等多个领域，是越南本土头部企业集团。
ICUI vs VFS — 直观对比
营收规模更大
VFS
是对方的1.3倍
$540.7M
净利率更高
VFS
高出0.1%
-2.9%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $718.6M |
| 净利润 | $-15.7M | $-20.0M |
| 毛利率 | 37.5% | — |
| 营业利润率 | 1.0% | -96.1% |
| 净利率 | -2.9% | -2.8% |
| 营收同比 | -14.1% | — |
| 净利润同比 | 34.0% | — |
| 每股收益（稀释后） | $-0.63 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUIVFS
| Q4 25 | $540.7M | — | ||
| Q3 25 | $537.0M | $718.6M | ||
| Q2 25 | $548.9M | $663.0M | ||
| Q1 25 | $604.7M | $656.5M | ||
| Q4 24 | $629.8M | — | ||
| Q3 24 | $589.1M | $511.6M | ||
| Q2 24 | $596.5M | — | ||
| Q1 24 | $566.7M | $302.6M |
净利润ICUIVFS
| Q4 25 | $-15.7M | — | ||
| Q3 25 | $-3.4M | $-20.0M | ||
| Q2 25 | $35.3M | $-51.8M | ||
| Q1 25 | $-15.5M | $-26.1M | ||
| Q4 24 | $-23.8M | — | ||
| Q3 24 | $-33.0M | $-10.4M | ||
| Q2 24 | $-21.4M | — | ||
| Q1 24 | $-39.5M | $-618.3M |
毛利率ICUIVFS
| Q4 25 | 37.5% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 34.8% | — | ||
| Q2 24 | 34.8% | — | ||
| Q1 24 | 32.7% | — |
营业利润率ICUIVFS
| Q4 25 | 1.0% | — | ||
| Q3 25 | 2.6% | -96.1% | ||
| Q2 25 | 1.9% | -79.0% | ||
| Q1 25 | 2.1% | -74.0% | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 1.4% | -65.9% | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | -1.9% | -139.4% |
净利率ICUIVFS
| Q4 25 | -2.9% | — | ||
| Q3 25 | -0.6% | -2.8% | ||
| Q2 25 | 6.4% | -7.8% | ||
| Q1 25 | -2.6% | -4.0% | ||
| Q4 24 | -3.8% | — | ||
| Q3 24 | -5.6% | -2.0% | ||
| Q2 24 | -3.6% | — | ||
| Q1 24 | -7.0% | -204.3% |
每股收益（稀释后）ICUIVFS
| Q4 25 | $-0.63 | — | ||
| Q3 25 | $-0.14 | — | ||
| Q2 25 | $1.43 | — | ||
| Q1 25 | $-0.63 | — | ||
| Q4 24 | $-0.97 | — | ||
| Q3 24 | $-1.35 | — | ||
| Q2 24 | $-0.88 | — | ||
| Q1 24 | $-1.63 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $8.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | — |
| 总资产 | $4.1B | $183.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ICUIVFS
| Q4 25 | — | — | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | — | $650.0M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | $308.6M | — | ||
| Q3 24 | $312.5M | $1.9M | ||
| Q2 24 | $302.6M | — | ||
| Q1 24 | $251.4M | $3.0M |
股东权益ICUIVFS
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $2.1B | $-7.2B | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $2.1B | — |
总资产ICUIVFS
| Q4 25 | $4.1B | — | ||
| Q3 25 | $4.1B | $183.2M | ||
| Q2 25 | $4.1B | $7.2B | ||
| Q1 25 | $4.2B | $158.2M | ||
| Q4 24 | $4.2B | — | ||
| Q3 24 | $4.3B | $151.8M | ||
| Q2 24 | $4.3B | — | ||
| Q1 24 | $4.3B | $145.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | — |
| 自由现金流经营现金流 - 资本支出 | $36.0M | — |
| 自由现金流率自由现金流/营收 | 6.6% | — |
| 资本支出强度资本支出/营收 | 4.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.8M | — |
8季度趋势，按日历期对齐
经营现金流ICUIVFS
| Q4 25 | $60.6M | — | ||
| Q3 25 | $56.7M | — | ||
| Q2 25 | $11.2M | — | ||
| Q1 25 | $51.3M | — | ||
| Q4 24 | $40.2M | — | ||
| Q3 24 | $36.1M | — | ||
| Q2 24 | $82.0M | — | ||
| Q1 24 | $45.8M | — |
自由现金流ICUIVFS
| Q4 25 | $36.0M | — | ||
| Q3 25 | $27.6M | — | ||
| Q2 25 | $-8.5M | — | ||
| Q1 25 | $36.7M | — | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $16.2M | — | ||
| Q2 24 | $62.5M | — | ||
| Q1 24 | $29.9M | — |
自由现金流率ICUIVFS
| Q4 25 | 6.6% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | -1.5% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 10.5% | — | ||
| Q1 24 | 5.3% | — |
资本支出强度ICUIVFS
| Q4 25 | 4.6% | — | ||
| Q3 25 | 5.4% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 2.8% | — |
现金转化率ICUIVFS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
VFS
| Sales of vehicles | $662.9M | 92% |
| Sales of spare parts and components | $41.3M | 6% |
| Revenue from leasing activities | $12.3M | 2% |
| Finance income | $2.4M | 0% |
| Rendering of services | $1.2M | 0% |
